相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Effects of Pegvisomant and Pasireotide LAR on Vertebral Fractures in Acromegaly Resistant to First-generation SRLs
Sabrina Chiloiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
An Effective and Practical Fluid Restriction Protocol to Decrease the Risk of Hyponatremia and Readmissions After Transsphenoidal Surgery
Dina Winograd et al.
NEUROSURGERY (2020)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Predictive factors for responses to primary medical treatment with lanreotide autogel 120 mg in acromegaly: post hoc analyses from the PRIMARYS study
Stephan Petersenn et al.
PITUITARY (2020)
Acromegaly and Vertebral Fractures: Facts and Questions
Andrea Giustina
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Pasireotide for acromegaly: long- term outcomes from an extension to the Phase III PAOLA study
Annamaria Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Pegvisomant and not somatostatin receptor ligands (SRLs) is first-line medical therapy for acromegaly
Aart J. van der Lely et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in Acromegaly
Eva C. Coopmans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review
Nidhi Agrawal et al.
PITUITARY (2020)
Pituitary Tumors Centers of Excellence
Stefano Frara et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2020)
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
Susan L. Samson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission
Marcelo Lemos Vieira da Cunha et al.
ENDOCRINE (2020)
Evolution of the graded repair of CSF leaks and skull base defects in endonasal endoscopic tumor surgery: trends in repair failure and meningitis rates in 509 patients
Andrew Conger et al.
JOURNAL OF NEUROSURGERY (2019)
Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study
Dale Ding et al.
NEUROSURGERY (2019)
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Monica R. Gadelha et al.
ENDOCRINE REVIEWS (2019)
Pegvisomant Improves Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
Tiziana Feola et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Acromegaly
Annamaria Colao et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Determinants of the growth hormone nadir during oral glucose tolerance test in adults
Katharina Schilbach et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
The effects of pre-operative somatostatin analogue therapy on treatment cost and remission in acromegaly
Ozge Polat Korkmaz et al.
PITUITARY (2019)
The optimal surgical techniques for pituitary tumors
M. Buchfelder et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal Study
Sabrina Chiloiro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Endocrine Outcomes After Pituitary Surgery
Anshu Buttan et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Management of Pituitary Adenomas Invading the Cavernous Sinus
Martin Rutkowski et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study
Andrea Giustina et al.
PITUITARY (2019)
Beyond the Learning Curve: Comparison of Microscopic and Endoscopic Incidences of Internal Carotid Injury in a Series of Highly Experienced Operators
Avital Perry et al.
WORLD NEUROSURGERY (2019)
Brazilian multicenter study on pegvisomant treatment in acromegaly
Cesar L. Boguszewski et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2019)
How and when to use temozolomide to treat aggressive pituitary tumours
Ben C. Whitelaw
ENDOCRINE-RELATED CANCER (2019)
Development of a novel patient-reported measure for acromegaly: the Acro-TSQ
Maria Fleseriu et al.
PITUITARY (2019)
A tale of pituitary adenomas: to NET or not to NET Pituitary Society position statement
Ken K. Y. Ho et al.
PITUITARY (2019)
Octreotide, 40 years later
Steven W. J. Lamberts et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study
Diogo Cordeiro et al.
JOURNAL OF NEUROSURGERY (2019)
AcroVoice: eliciting the patients' perspective on acromegaly disease activity
Yanina Jackson et al.
PITUITARY (2019)
Long-Term Efficacy and Tolerability of Gamma Knife Radiosurgery for Growth Hormone-Secreting Adenoma: A Retrospective Multicenter Study (MERGE-001)
Doo-Sik Kong et al.
WORLD NEUROSURGERY (2019)
Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors
Kosaku Amano et al.
ACTA NEUROCHIRURGICA (2019)
Effectiveness and safety of pegvisomant: a systematic review and meta-analysis of observational longitudinal studies
Leticia P. Leonart et al.
ENDOCRINE (2019)
Pegvisomant in acromegaly: a multicenter real-life study in Argentina
Natalia Ximena Garcia Basavilbaso et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2019)
Efficacy and safety of fractionated conformal radiation therapy in acromegaly: a long-term follow-up study
Baldomero Gonzales-Virla et al.
ENDOCRINE (2019)
The burden of disease for pituitary patients
Nienke R. Biermasz
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy
Thierry Brue et al.
ENDOCRINE (2019)
Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
Ammar Muhammad et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature
Joao Paulo Almeida et al.
JOURNAL OF NEUROSURGERY (2018)
Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience
Liang Lv et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Increasing frequency of combination medical therapy in the treatment of acromegaly with the GH receptor antagonist pegvisomant
Christian J. Strasburger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly
Baldomero Gonzalez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience
Elisa Sala et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Biochemical efficacy of long-acting lanreotide depot/Autogel in patients with acromegaly naive to somatostatin-receptor ligands: analysis of three multicenter clinical trials
Hussain Alquraini et al.
PITUITARY (2018)
Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas
Sema Ciftci Dogansen et al.
PITUITARY (2018)
A Consensus Statement on acromegaly therapeutic outcomes
Shlomo Melmed et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
The experience with transsphenoidal surgery and its importance to outcomes
Juergen Honegger et al.
PITUITARY (2018)
Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
Michael Buchfelder et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly
F. Albarel et al.
PITUITARY (2018)
Predictors of surgical outcome and early criteria of remission in acromegaly
Ximene Antunes et al.
ENDOCRINE (2018)
Microsurgical therapy of pituitary adenomas
Pietro Mortini et al.
ENDOCRINE (2018)
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues
S. E. Franck et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2017)
Characteristics of meningitis following transsphenoidal endoscopic surgery: a case series and a systematic literature review
Pasquale Pagliano et al.
INFECTION (2017)
High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
Andrea Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly
Rudolf Fahlbusch et al.
PITUITARY (2017)
T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective
Iulia Potorac et al.
PITUITARY (2017)
Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly
Aart J. van der Lely et al.
PITUITARY (2017)
Biochemical investigations in diagnosis and follow up of acromegaly
Katharina Schilbach et al.
PITUITARY (2017)
Updates in outcomes of stereotactic radiation therapy in acromegaly
Monica Livia Gheorghiu
PITUITARY (2017)
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Felipe F. Casanueva et al.
PITUITARY (2017)
Pegvisomant in acromegaly: an update
A. Giustina et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2017)
Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications
Ching-Jen Chen et al.
ACTA NEUROCHIRURGICA (2017)
Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY
Aart Jan van der Lely et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Delayed Hyponatremia Is the Most Common Cause of 30-Day Unplanned Readmission After Transsphenoidal Surgery for Pituitary Tumors
Michael A. Bohl et al.
NEUROSURGERY (2016)
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly
Marco Losa et al.
ENDOCRINE (2016)
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly
Herbert A. Schmid et al.
ENDOCRINE (2016)
Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification
Alexander S. G. Micko et al.
JOURNAL OF NEUROSURGERY (2015)
Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system
V. S. Nunes et al.
PITUITARY (2015)
Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach
N. Sandow et al.
PITUITARY (2015)
Octreotide LAR treatment of acromegaly in real life: long-term outcome at a tertiary care center
Ana Laura Espinosa-de-los-Monteros et al.
PITUITARY (2015)
Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
Philippe J. Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Commentary: Postsurgical Monitoring of Acromegaly
Andrea Giustina et al.
NEUROSURGERY (2013)
Pegvisomant and cabergoline combination therapy in acromegaly
I. Bernabeu et al.
PITUITARY (2013)
A consensus on the diagnosis and treatment of acromegaly complications
S. Melmed et al.
PITUITARY (2013)
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Andrea Giustina et al.
PLOS ONE (2012)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Current management practices for acromegaly: an international survey
A. Giustina et al.
PITUITARY (2011)
Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
Manel Puig-Domingo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
Gherardo Mazziotti et al.
PITUITARY (2010)
SURGICAL REINTERVENTION IN ACROMEGALY: IS IT STILL WORTH TRYING?
Ana Laura Espinosa de los Monteros et al.
ENDOCRINE PRACTICE (2009)
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
Andrea Giustina et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Influence of Growth Hormone Receptor d3 and Full-Length Isoforms on Biochemical Treatment Outcomes in Acromegaly
Antonio Bianchi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
John D. Carmichael et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
IGF-I assays: current assay methodologies and their limitations
David R. Clemmons
PITUITARY (2007)
Postoperative evaluation of patients with acromegaly: Clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels
RA Feelders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
G Minniti et al.
CLINICAL ENDOCRINOLOGY (2005)
Long-term effects of lanreotide SR and octreotide LAR (R) on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly
G Amato et al.
CLINICAL ENDOCRINOLOGY (2002)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely et al.
LANCET (2001)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
PJ Trainer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
